Olympus Corp., founded in 1919 and headquartered in Japan, specializes in optical and digital precision technology aimed at medical and industrial solutions. The company is well-known for its advanced endoscopic imaging systems, microscopes, and medical devices that enhance patient care and operational efficiency across various healthcare settings.
| Bond Name | Country | Maturity | Coupon(%) | |
|---|---|---|---|---|
| OLYMPU 0.25% 2025-07-18 JPYOlympus Corp. | Japan | 2025-07-18 | 0.250 | 0.00 |
| OLYMPU 0.47% 2030-07-19 JPYOlympus Corp. | Japan | 2030-07-19 | 0.470 | 1.96 |
| OLYMPU 2.14% 2026-12-08 USDOlympus Corp. | Japan | 2026-12-08 | 2.143 | 4.05 |
| OLYMPU 2.14% 2026-12-08 USDOlympus Corp. | Japan | 2026-12-08 | 2.143 | 4.05 |
Company overview and issue history are AI generated, and should not be cited or relied on without verification.
Olympus Corp. began issuing bonds in the 1990s to support its growth and expansion. Notably, in 2020, the company issued a ¥30 billion (approx. $275 million) bond that attracted significant investor interest, reflecting favorable market conditions and a strong emphasis on R&D investments. Current yields on Olympus bonds are competitive within the healthcare technology sector, and the company successfully includes features like green bonds aimed at sustainability initiatives. Recently, Olympus has been in news for plans to invest in innovative technologies, positioning it well for future bond offerings and attracting investor confidence.